Explore

Slice the corpus on any axis.

Filter by firm, year, function, metric or slide category — then see the result as a narrative arc, a treemap of slide types, or a catalog of slides.

clear
51,416 slides across 1229 decks match.
Treemap Arc Catalog
These unmet needs call for innovations on both existing vaccines and new products
McKinsey · 2016 · problem_statement
These unmet needs call for innovations on both existing vaccines and new products
 Several existing vaccines still fall short on fully addressing public health needs
McKinsey · 2016 · problem_statement
Several existing vaccines still fall short on fully addressing public health needs
453 — Deaths per year
 Increasing complexity in patient diversity and program delivery also raises the need for product improvements
McKinsey · 2016 · problem_statement
Increasing complexity in patient diversity and program delivery also raises the need for product improvements
9 — Vaccination rate
 There are several high-burden and high-priority diseases for which we do not yet have vaccines on the market
McKinsey · 2016 · problem_statement
There are several high-burden and high-priority diseases for which we do not yet have vaccines on the market
1,341 — Deaths per year
 At first glance, the industry looks to be thriving – pipelines are robust, and revenues are growing
McKinsey · 2016 · context
At first glance, the industry looks to be thriving – pipelines are robust, and revenues are growing
 The vaccine product pipeline has been growing at a healthy rate over the last decade
McKinsey · 2016 · industry_trends
The vaccine product pipeline has been growing at a healthy rate over the last decade
266 — Number of vaccines in development
 We have a higher proportion of late stage vaccine candidates now than we did in 2005
McKinsey · 2016 · data_table
We have a higher proportion of late stage vaccine candidates now than we did in 2005
56 — Share of candidates
 As the pipeline has continued to grow, so have the number of new product launches worldwide
McKinsey · 2016 · industry_trends
As the pipeline has continued to grow, so have the number of new product launches worldwide
96 — Number of vaccine launches
 Global industry growth has also kept pace, and is expected to continue to grow at close to double-digits through 2020
McKinsey · 2016 · market_landscape
Global industry growth has also kept pace, and is expected to continue to grow at close to double-digits through 2020
$39-48bn — Global vaccine sales
 Growth in the global vaccine market has and will continue to out-pace that of the rest of the pharma industry
McKinsey · 2016 · industry_trends
Growth in the global vaccine market has and will continue to out-pace that of the rest of the pharma industry
22% — Annual growth rate
 However, looking closer, signals suggest that there are real challenges to innovation
McKinsey · 2016 · transition
However, looking closer, signals suggest that there are real challenges to innovation
 The majority of the market growth has come from existing vaccines rather than new launches
McKinsey · 2016 · market_landscape
The majority of the market growth has come from existing vaccines rather than new launches
-21% — Market share by product age
 Biotechs are driving most early stage programs, but facing limitations in the absorptive capacity of big pharma to take innovations to market
McKinsey · 2016 · industry_trends
Biotechs are driving most early stage programs, but facing limitations in the absorptive capacity of big pharma to take innovations to market
113 — Number of vaccine development programs
 Vaccine candidates are killed earlier than biologics, and we get fewer shots on goal
McKinsey · 2016 · diagnosis
Vaccine candidates are killed earlier than biologics, and we get fewer shots on goal
48% — Attrition rate
 Three factors are challenging the underlying business model for vaccines innovation
McKinsey · 2016 · problem_statement
Three factors are challenging the underlying business model for vaccines innovation
 Vaccines businesses are on a trend of declining profitability, placing increasing pressure on the economics
McKinsey · 2016 · financial_analysis
Vaccines businesses are on a trend of declining profitability, placing increasing pressure on the economics
100 — Indexed operating margin
 Relative vaccine economics have been changing, with lower returns on investment as success rates converge with biologics
McKinsey · 2016 · industry_trends
Relative vaccine economics have been changing, with lower returns on investment as success rates converge with biologics
16% — Success rate
 We see three potential drivers challenging the business model
McKinsey · 2016 · pain_points
We see three potential drivers challenging the business model
 Time to market for vaccines is increasing, implying increasing costs and creating potential economic uncertainty
McKinsey · 2016 · problem_statement
Time to market for vaccines is increasing, implying increasing costs and creating potential economic uncertainty
+27% — Time to market
 Shortages, recalls and other manufacturing challenges and required investments add additional risks to the economics
McKinsey · 2016 · precedent
Shortages, recalls and other manufacturing challenges and required investments add additional risks to the economics
 Commercial attractiveness and technical feasibility vary by vaccine and vaccine archetype
McKinsey · 2016 · framework_other
Commercial attractiveness and technical feasibility vary by vaccine and vaccine archetype
 The low-hanging fruit no longer exists – needed innovations will be less commercially attractive and less technically feasible than in the past
McKinsey · 2016 · framework_2x2
The low-hanging fruit no longer exists – needed innovations will be less commercially attractive and less technically feasible than in the past
 Five vaccine archetypes carry distinct profiles for commercial potential and technical feasibility
McKinsey · 2016 · segmentation
Five vaccine archetypes carry distinct profiles for commercial potential and technical feasibility
 There are several potential solutions to re-fuel the vaccines innovation engine
McKinsey · 2016 · transition
There are several potential solutions to re-fuel the vaccines innovation engine
 NVAC could play a lead role in some of these potential solutions
McKinsey · 2016 · strategic_options
NVAC could play a lead role in some of these potential solutions
 Several existing vaccines still fall short on fully addressing public health needs
McKinsey · 2016 · problem_statement
Several existing vaccines still fall short on fully addressing public health needs
453 — Deaths per year
 Our study has uncovered several key economic and employment impacts of Ford and its F-Series production
BCG · 2020 · executive_summary
Our study has uncovered several key economic and employment impacts of Ford and its F-Series production
500,000 — Total jobs supported
 The F-Series supports ~500,000 American jobs, representing ~13–14 jobs for every direct Ford employee
BCG · 2020 · impact_sizing
The F-Series supports ~500,000 American jobs, representing ~13–14 jobs for every direct Ford employee
~500,000 — Total US jobs supported
 Ford USA supports ~1 million American jobs, representing ~11–12 jobs for every direct Ford employee
BCG · 2020 · impact_sizing
Ford USA supports ~1 million American jobs, representing ~11–12 jobs for every direct Ford employee
~1 million — Total jobs supported
 F-Series trucks are used by and support up to 13M Americans in their daily work
BCG · 2020 · impact_sizing
F-Series trucks are used by and support up to 13M Americans in their daily work
13M — US labor force supported
 The F-Series contributes ~$49 billion to US GDP through production and multiplier effects
BCG · 2020 · financial_analysis
The F-Series contributes ~$49 billion to US GDP through production and multiplier effects
$49 billion — US GDP contribution
 Ford USA contributes ~$100 billion to US GDP through production and multiplier effects
BCG · 2020 · financial_analysis
Ford USA contributes ~$100 billion to US GDP through production and multiplier effects
$100 billion — US GDP contribution
 Ford assembled twice as many full-size pickups in the US as any competitor in 2019
BCG · 2020 · competitive_analysis
Ford assembled twice as many full-size pickups in the US as any competitor in 2019
2.1x — Full-size pickup trucks assembled
 Ford is responsible for one in five vehicles assembled in the US
BCG · 2020 · market_landscape
Ford is responsible for one in five vehicles assembled in the US
20% — US vehicle assembly share
 An external study confirms the F-150 is the most American-made full-size pickup
BCG · 2020 · competitive_analysis
An external study confirms the F-150 is the most American-made full-size pickup
78 — Made in America Index score
 Ford is a leader in the automotive industry for combined quality and recency of patent filings
BCG · 2020 · competitive_analysis
Ford is a leader in the automotive industry for combined quality and recency of patent filings
 Ford's IP is supporting innovation across industries
BCG · 2020 · client_example
Ford's IP is supporting innovation across industries
~23,000 — Patent citations
 Ford is investing in the future of mobility
BCG · 2020 · competitive_analysis
Ford is investing in the future of mobility
84% — Future of mobility patent families
 The F-Series is among the largest US consumer products—bigger than Android and combined major sports leagues
BCG · 2020 · market_landscape
The F-Series is among the largest US consumer products—bigger than Android and combined major sports leagues
$42 billion — Revenue ($billions)
 The F-Series alone generated more revenue than many recognizable companies in 2019
BCG · 2020 · competitive_analysis
The F-Series alone generated more revenue than many recognizable companies in 2019
$42bn — 2019 revenue ($billions)
 The F-Series is the most popular vehicle on the road in the US today
BCG · 2020 · market_landscape
The F-Series is the most popular vehicle on the road in the US today
5.7% — Share of vehicles in operation
 The F-150 is the most popular vehicle on the road in 39 of 50 US states
BCG · 2020 · geographic_map
The F-150 is the most popular vehicle on the road in 39 of 50 US states
39 — Number of states
 The F-Series is the highest-selling vehicle in the US over the last ten years
BCG · 2020 · competitive_analysis
The F-Series is the highest-selling vehicle in the US over the last ten years
7,579 — Cumulative vehicle sales (thousands)
 The F-Series is the best-selling pickup truck in the world over the last ten years
BCG · 2020 · competitive_analysis
The F-Series is the best-selling pickup truck in the world over the last ten years
9,124 — Global vehicle sales (thousands)
 Ford is the most popular pickup truck across commercial vocations
BCG · 2020 · competitive_analysis
Ford is the most popular pickup truck across commercial vocations
75% — Market share
 AI Strategy Driven by Super Use Cases
IDC · context
AI Strategy Driven by Super Use Cases
 Strategy Spotlight: High Business Value and Feasibility in Use Case Prioritization
IDC · framework_2x2
Strategy Spotlight: High Business Value and Feasibility in Use Case Prioritization
 From Silos to Synergy: Transforming Organizations with Unified AI Platforms
IDC · process_diagram
From Silos to Synergy: Transforming Organizations with Unified AI Platforms
75% — enterprise value
Next page →